| Myeloid cell-derived reactive oxygen species induce epithelial mutagenesis Ö Canli, AM Nicolas, J Gupta, F Finkelmeier, O Goncharova, M Pesic, ... Cancer cell 32 (6), 869-883. e5, 2017 | 280 | 2017 |
| Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer AM Nicolas, M Pesic, E Engel, PK Ziegler, M Diefenhardt, KB Kennel, ... Cancer Cell 40 (2), 168-184. e13, 2022 | 143 | 2022 |
| A Wnt-induced phenotypic switch in cancer-associated fibroblasts inhibits EMT in colorectal cancer MH Mosa, BE Michels, C Menche, AM Nicolas, T Darvishi, FR Greten, ... Cancer research 80 (24), 5569-5582, 2020 | 83 | 2020 |
| Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade C Conche, F Finkelmeier, M Pešić, AM Nicolas, TW Böttger, KB Kennel, ... Gut 72 (9), 1774-1782, 2023 | 74 | 2023 |
| AKT-dependent NOTCH3 activation drives tumor progression in a model of mesenchymal colorectal cancer J Varga, A Nicolas, V Petrocelli, M Pesic, A Mahmoud, BE Michels, ... Journal of Experimental Medicine 217 (10), e20191515, 2020 | 63 | 2020 |
| Expansion of T memory stem cells with superior anti-tumor immunity by Urolithin A-induced mitophagy D Denk, V Petrocelli, C Conche, M Drachsler, PK Ziegler, A Braun, ... Immunity 55 (11), 2059-2073. e8, 2022 | 43 | 2022 |
| Colon tumour cell death causes mTOR dependence by paracrine P2X4 stimulation M Schmitt, F Ceteci, J Gupta, M Pesic, TW Böttger, AM Nicolas, KB Kennel, ... Nature 612 (7939), 347-353, 2022 | 34 | 2022 |
| Disruption of prostaglandin E2 signaling in cancer-associated fibroblasts limits mammary carcinoma growth but promotes metastasis E Elwakeel, M Brüggemann, J Wagih, O Lityagina, MAF Elewa, Y Han, ... Cancer Research 82 (7), 1380-1395, 2022 | 11 | 2022 |
| ACO/ARO/AIO-21-Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist anakinra for rectal cancer Patients: A phase I trial of the German rectal … M Fleischmann, M Diefenhardt, AM Nicolas, F Rödel, M Ghadimi, ... Clinical and translational radiation oncology 34, 99-106, 2022 | 10 | 2022 |
| Image-guided radiotherapy in an orthotopic mouse model of rectal cancer AM Nicolas, M Pesic, F Rödel, E Fokas, FR Greten STAR protocols 3 (4), 101749, 2022 | 2 | 2022 |
| Means for reducing radio-and chemotherapy resistance and adverse effects F Greten, A Nicolas, C Rödel, E Fokas US Patent App. 18/245,529, 2023 | | 2023 |
| ACO/ARO/AIO-21: Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist Anakinra for rectal cancer patients. A phase I trial of the German Rectal … E Fokas, A Nicolas, M Fleischmann, F Roedel, M Ghadimi, RD Hofheinz, ... STRAHLENTHERAPIE UND ONKOLOGIE 198 (SUPPL 1), S109-S110, 2022 | | 2022 |
| Inflammatory cancer associated fibroblasts decisive role in therapy resistance among rectal cancer patients AM Nicolas Dissertation, Frankfurt am Main, Johann Wolfgang Goethe-Universität, 2022, 0 | | |
